Advertisement

Topics

First non-opioid-based therapy for opioid withdrawal symptoms wins US backing

10:20 EDT 17 May 2018 | thePharmaLetter

Specialty pharma firm US WorldMeds has been approved to market Lucemyra (lofexidine), the firm’s opioid…

Original Article: First non-opioid-based therapy for opioid withdrawal symptoms wins US backing

NEXT ARTICLE

More From BioPortfolio on "First non-opioid-based therapy for opioid withdrawal symptoms wins US backing"

Advertisement
Quick Search
Advertisement
Advertisement